Logo
  • Home
  • Press Releases

TGV-inhalonix’s New Drug To Help Patients With Resistant Fungal Lung Infections

New York, New York, USA, 05/11/2017 /SubmitPressRelease123/

TGV-inhalonix, a New York drug development company behind ground-breaking Mul-1867 which gives hope to treating life-threatening, antibiotic-resistant bacterial lung infections in patients suffering from cystic fibrosis, announced that Mul-1867 has shown tremendous potential against clinical isolates of fungi from patients with cystic fibrosis and other severe lung infections.

The findings were published in Europe’s leading discovery journal –  International Journal of Antimicrobial Agents – and will be presented at the upcoming ASM – 2017 conference in June.

The article written by Victor and George Tetz, the scientific core at TGV-inhalonix, details the results of a collaborative study along with VA Medical Center and University of Massachusetts for antifungal activity of Mul-1867. The authors report that they revealed high activity of Mul-1867 against multidrug-resistant strains of Candida spp and Aspergillus spp, which are especially risky for people with cystic fibrosis and patients with compromised immune system including those with lung transplans. “Fungal infections represent a crucial and unsolved problem for patients with cystic fibrosis, playing a dramatic role in their morbidity,” as stated by the researchers.  

“We have already confirmed a broad spectrum activity of Mul-1867 against multiresistant bacterial isolates such as S.aureus and P.aeruginosa along with early, compassionate use human clinical data. Its high anti-infective efficacy could make it a breakthrough new agent for addressing a variety of lung infections starting with those in Cystic Fibrosis patients,” said Dr. George Tetz.

For a few decades, the problem of antibiotic resistant fungal infections posed treatment challenges in patients suffering from a variety of pathologies and finding a solution is crucial for cystic fibrosis patients. “Our studies indicate that Mul-1687 also holds promise as a treatment against numerous other lung indications with fungal etiology, including HIV, blood malignancies and can help patients undergoing lung transplantations. We believe our research has unlocked a key for slowing the growth of these potentially fatal antibiotic-resistant pathogens,” said Dr. Victor Tetz.

“The recent increase in the incidence of life-threatening infections caused by resistant fungi, including Candida and Aspergillus, is particularly concerning, because currently available antifungal agents may no longer be effective,” said Dr. Haran T Schlamm of HTS Pharma Consulting, LLC, an advisor to TGV-Inhalonix.

TGV-inhalonix has recently obtained an Orphan Drug status for Mul-1867, which will provide incentives to develop drugs for treating rare diseases.

The research from the TGV-inhalonix study has also been accepted to an upcoming ASM Microbe 2017 conference and European Cystic Fibrosis Conference 2017, both of which will take place in June.

********************************************************************

For more information about Victor and George Tetz and TGV-Inhalonix, please contact Dan Wilson at 646 214 8010, Email: [email protected]

 

Social Media Tags:new drug, Cystic Fibrosis, TGV-inhalonix, Orphan Drug, Mul-1867

Newsroom powered by Online Press Release Distribution – SubmitMyPressRelease.com

Like Us on Facebook

It's only fair to share...Pin on Pinterest
Pinterest
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Email this to someone
email
Print this page
Print
Tags: Cystic Fibrosis, Mul-1867, new drug, Orphan Drug, TGV-inhalonix
May 11, 2017   vision
Health & Fitness, Medical News, Press Releases Cystic Fibrosis, Mul-1867, new drug, Orphan Drug, TGV-inhalonix
×

  • Top Reasons You Need to Be Using HEPA Filters
  • Farida Is A Brilliant And Talented Actress Who Has Brought Tears To Audiences
Categories
  • Arabic PR
  • Art
  • Auto News
  • aviation news
  • Bollywood News
  • BP OIL Spill News
  • Business
  • California
  • Call Center News
  • Copyright Law
  • Dallas News
  • e-commerce
  • Education
  • Electronics
  • Employment Law
  • Entertainment
  • Family law
  • Fashion
  • Food & Beverage
  • golf news
  • Green
  • Health & Fitness
  • Hollywood News
  • home decor
  • insurance
  • iPhoneNews
  • Law
  • Media News
  • Medical News
  • Mesothelioma Asbestos
  • military-news
  • Money & Finance
  • music news
  • new york
  • New York City
  • News
  • Noticias en español
  • Opinions
  • Personal Finance
  • Personal Injury Law News
  • Press Releases
  • Real Estate
  • Religious News
  • Restaurant Reviews
  • Social Media News
  • Social Responsibility
  • South Florida News
  • Sports
  • Technology
  • Top Stories
  • travel
  • UK Press Release
  • US Presidential News
  • VoIP News
  • Weather
  • Web Technology
  • Weddings
  • whistleblower
  • World News
Recent Posts

Rehabs Near Me Launches New Rehab Services in the US

February 25, 2021, Comments Off on Rehabs Near Me Launches New Rehab Services in the US

Expert Biloxi Roofing Contractors Keeping Properties in Top-Notch Condition

February 24, 2021, Comments Off on Expert Biloxi Roofing Contractors Keeping Properties in Top-Notch Condition

Meta Slim Complete Reviews: Critical Ingredients and Side Effects Report! By Derekblog

February 24, 2021, Comments Off on Meta Slim Complete Reviews: Critical Ingredients and Side Effects Report! By Derekblog
Tags
asbestos Business California cancer clean air solutions clouse dunn khoshbin Dallas dallas employment death economy Education employment law attorney Employment Lawyer employment lawyers facebook Florida google government Health Hollywood insurance jonathan c reiter Lawsuit lawyer marketing Los Angeles marketing mesothelioma mortgage new york New York City nfm lending Obama Parcel2Go president Real Estate recession Search Engine Optimization SEO social media study Texas texas employment Twitter U.S. Washington
News Tags >>

  • Our News on Google News
  • Yahoo News
  • Writing a Press Release
  • Press Release Distribution Services
  • A Sample Press Release Template
  • Social Media News Distribution
  • Search Engine Optimized Press Release
  • Online News Distribution Benefits
  • Dallas News
  • Latest Press Releases
  • Lawyer Press Release Service
  • News on Major online news sites
  • Press Release Service WiredPRNew.com
Copyright © 2021 WiredPRNews.com